How can cobicistat-containing medicines affect the risk of systemic side effects from methylprednisolone?

Cobicistat-containing medicines are expected to increase the risk of systemic side effects from methylprednisolone; the combination should be avoided unless the benefit outweighs the increased risk, in which case patients should be monitored for systemic corticosteroid side effects.